Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-8 of Intrexon Corporation of our report dated February 24, 2016, relating to the financial statements of ZIOPHARM Oncology, Inc., appearing in Intrexon Corporation’s Annual Report on Form 10-K for the year ended December 31, 2016.
/s/ RSM US LLP
Boston, Massachusetts
August 10, 2017